Frailty and outcomes in older adults with pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study looks at how frailty (overall weakness and decline) affects recovery in older adults who come to the emergency room with pneumonia. The goal is to understand what outcomes patients can expect based on their frailty level.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have been diagnosed with pneumonia in the emergency room (using an X-ray or CT scan).
- You or a family member can sign a consent form to participate.
- Someone who knows you well (like a caregiver or relative) can tell us how you were functioning before you got sick.
- You are not currently in cardiac arrest or needing CPR.
- Your pneumonia is not due to COVID-19.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether frailty (how weak or vulnerable someone is) changes the risk of heart-related events and death in people with COPD. It may help doctors better predict who is at higher risk and tailor care.
This study looks at how frailty (overall weakness and vulnerability) affects recovery, disability, and quality of life in older adults after a serious ICU stay. It aims to understand how pre-existing frailty influences outcomes to improve care for older ICU patients.
This study looks at frailty (a state of increased weakness and lower energy) and what factors are linked to it in older adults (60+) who are in the hospital. By joining, you help researchers better understand frailty, which could lead to better care for older patients.
This study looks at how different factors—like health, mental well-being, and social support—work together to predict frailty in older adults. The goal is to better understand frailty in men and women, which may help doctors provide more personalized care.
This trial looks at ways to help “frailty” (low strength and resilience) in people staying in intensive care units. It mainly enrolls adults who expect to be in the ICU for more than 24 hours, and it tries to avoid people whose mobility problems have other causes.
This study looks at people with COPD or ILD who also show signs of frailty. It aims to understand how frailty and muscle loss (sarcopenia) affect their care and use of medical resources over time.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.